Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Placenta ; 29(7): 631-8, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18538388

RESUMO

Human placentas are sources of cytokines, hormones and other substances that program receptive cells. One of these substances is HLA-G, which influences the functioning of both leukocytes and endothelial cells. In this study, we investigated the possibility that these and/or other types of cells in extraembryonic fetal tissues might respond to HLA-G by interacting with one or another of the leukocyte immunoglobulin-like receptors (LILR). LILRB1 is expressed by most leukocytes and LILRB2 is expressed primarily by monocytes, macrophages and dendritic cells. Analysis of term placentas by immunohistochemistry and Real Time PCR demonstrated that LILRB1 and LILRB2 protein and specific messages are produced in the mesenchyme of term villous placenta but are differently localized. LILRB1 was abundant in stromal cells and LILRB2 was prominent perivascularly. Neither receptor was identified in trophoblast. Further investigation using double label immunofluorescence indicated that placental vascular smooth muscle but not endothelia exhibit LILRB2. Term umbilical cord exhibited the same LILRB2 patterns as term placenta. Samples obtained by laser capture dissection of vascular smooth muscle in umbilical cords demonstrated LILRB2 mRNA, and double label immunofluorescence showed that cord vascular smooth muscle but not endothelium exhibited LILRB2 protein. The presence of LILRB1 in placental stromal cells and LILRB2 in vascular smooth muscle strongly suggest that HLA-G has novel functions in these tissues that could include regulation of placental immunity as well as development and function of the extraembryonic vasculature.


Assuntos
Antígenos HLA/metabolismo , Antígenos de Histocompatibilidade Classe I/metabolismo , Placenta/metabolismo , Receptores Imunológicos/genética , Cordão Umbilical/metabolismo , Antígenos CD/genética , Antígenos CD/metabolismo , Células Cultivadas , Membranas Extraembrionárias/irrigação sanguínea , Membranas Extraembrionárias/metabolismo , Feminino , Antígenos HLA/fisiologia , Antígenos HLA-G , Antígenos de Histocompatibilidade Classe I/fisiologia , Humanos , Imunidade Inata/genética , Receptor B1 de Leucócitos Semelhante a Imunoglobulina , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Mesoderma/metabolismo , Músculo Liso Vascular/metabolismo , Miócitos de Músculo Liso/metabolismo , Placenta/irrigação sanguínea , Placenta/imunologia , Placentação , Gravidez , Ligação Proteica , RNA Mensageiro/metabolismo , Receptores Imunológicos/metabolismo
2.
Placenta ; 26 Suppl A: S104-9, 2005 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15837058

RESUMO

Maternal antigen presenting cells, which are macrophages and dendritic cells, are scattered throughout human decidualized endometrium during all stages of pregnancy. These powerful, multi-functional leukocytes reside in close proximity to uterine glandular epithelium, uterine blood vessels, and HLA-G-producing invasive cytotrophoblast cells. Macrophages and dendritic cells, which express the HLA-G receptors, ILT2 and ILT4, play major roles in driving innate and adaptive immune responses, altering the behavior of local stromal cells, shaping the cytokine microenvironment, and protecting the tissue from infection. Therefore, encounters between decidual antigen presenting cells and HLA-G molecules are likely to influence uterine and placental homeostasis as well as local maternal immune responses to the fetus during pregnancy.


Assuntos
Células Apresentadoras de Antígenos/imunologia , Decídua/imunologia , Antígenos HLA/metabolismo , Antígenos de Histocompatibilidade Classe I/metabolismo , Células Apresentadoras de Antígenos/citologia , Apoptose , Citocinas/biossíntese , Decídua/citologia , Células Dendríticas/imunologia , Feminino , Antígenos HLA/genética , Antígenos HLA-G , Antígenos de Histocompatibilidade Classe I/genética , Humanos , Tolerância Imunológica , Macrófagos/imunologia , Troca Materno-Fetal/imunologia , Modelos Imunológicos , Fenótipo , Gravidez , Receptores Imunológicos/metabolismo
3.
Clin Nucl Med ; 6(10): 476-8, 1981 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-7028339

RESUMO

In the high-risk neonate, the direct determination of the red cell volume by radionuclide dilution technique appears to be the singularly definitive method of defining treatment efficacy, and is thus a useful evaluation and management tool for the pediatrician. For effective patient management, the red blood cell(RBC) volume of 69 preterm and term neonates was determined. The method utilized, Tc-99m-labeled RBCs, provided a fast and accurate answer with a large reduction in the absorbed radiation dose. In the population studied within a high-risk newborn ICU, the mean RBC volumes between the preterm and term neonates were without significant difference. Grouping and analysis of the RBC volume data with respect to birth weight, gestational ages, and 1- and 5-minute Apgar scores revealed on statistical difference. The mean value found in our population, 32.2 +/- 9.2 ml/kg, however, does differ from those previously reported in which the determinations were made using an indirect estimation from the plasma compartment.


Assuntos
Volume de Eritrócitos , Recém-Nascido , Recém-Nascido Prematuro , Tecnécio , Índice de Apgar , Peso ao Nascer , Radioisótopos de Cromo , Eritrócitos , Idade Gestacional , Humanos , Doses de Radiação , Técnica de Diluição de Radioisótopos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA